The Growing Problem of Peripheral Neuropathy in Prediabetes
Early intervention is essential to treating neuropathy in those with prediabetes.
Early intervention is essential to treating neuropathy in those with prediabetes.
Induced pluripotent stem cells offer a new way to study insulin resistance and other metabolic disorders in humans.
During the past 50 years, diabetes research and management has come a long way, although there is still work to be done.
Activity in certain brain regions of teenagers with type 1 diabetes was increased or decreased with hyperglycemia and hypoglycemia.
PE0139, a super long-acting basal insulin, and PB1023, a weekly GLP-1 receptor agonist, may lead to novel approach to treating diabetes.
Unsupervised closed loop insulin delivery is safe and feasible in the home setting in teens with type 1 diabetes.
Adding liraglutide to insulin in a closed loop system may reduce postprandial hyperglycemia as well as insulin requirements, compared with insulin monotherapy.
Children may have a higher risk for fat accumulation and insulin resistance if their mothers were obese.
Food insecurity has an impact on glycemic control and vegetable consumption in Latino patients with diabetes.
GLP-1 receptor agonist may be able to reduce glycemic variability rather than a prandial insulin.